BML Inc
TSE:4694

Watchlist Manager
BML Inc Logo
BML Inc
TSE:4694
Watchlist
Price: 2 939 JPY 1.1% Market Closed
Market Cap: 114.6B JPY
Have any thoughts about
BML Inc?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
BML Inc

Revenue
139.2B JPY
Cost of Revenue
-93.5B JPY
Gross Profit
45.7B JPY
Operating Expenses
-36.5B JPY
Operating Income
9.2B JPY
Other Expenses
-3.1B JPY
Net Income
6.1B JPY

Margins Comparison
BML Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
JP
BML Inc
TSE:4694
114.6B JPY
33%
7%
4%
US
Cigna Group
XMUN:CGN
75.6B EUR
11%
4%
1%
US
Cigna Corp
NYSE:CI
77.9B USD
11%
4%
1%
US
CVS Health Corp
NYSE:CVS
56B USD
14%
3%
1%
DE
Fresenius Medical Care AG
XMUN:FME
26B EUR
25%
7%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR
24%
7%
-2%
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD
28%
9%
3%
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD
19%
8%
-2%
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD
33%
14%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR
25%
7%
3%
US
DaVita Inc
NYSE:DVA
12.7B USD
33%
15%
7%
Country JP
Market Cap 114.6B JPY
Gross Margin
33%
Operating Margin
7%
Net Margin
4%
Country US
Market Cap 75.6B EUR
Gross Margin
11%
Operating Margin
4%
Net Margin
1%
Country US
Market Cap 77.9B USD
Gross Margin
11%
Operating Margin
4%
Net Margin
1%
Country US
Market Cap 56B USD
Gross Margin
14%
Operating Margin
3%
Net Margin
1%
Country DE
Market Cap 26B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country DE
Market Cap 18.8B EUR
Gross Margin
24%
Operating Margin
7%
Net Margin
-2%
Country US
Market Cap 19.3B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
3%
Country US
Market Cap 16.9B USD
Gross Margin
19%
Operating Margin
8%
Net Margin
-2%
Country US
Market Cap 17.1B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
Country DE
Market Cap 13B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country US
Market Cap 12.7B USD
Gross Margin
33%
Operating Margin
15%
Net Margin
7%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
BML Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
JP
BML Inc
TSE:4694
114.6B JPY
5%
4%
7%
8%
US
Cigna Group
XMUN:CGN
75.6B EUR
7%
2%
10%
7%
US
Cigna Corp
NYSE:CI
77.9B USD
7%
2%
10%
7%
US
CVS Health Corp
NYSE:CVS
56B USD
7%
2%
7%
4%
DE
Fresenius Medical Care AG
XMUN:FME
26B EUR
4%
2%
5%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR
-2%
-1%
4%
1%
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD
5%
2%
8%
5%
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD
-2%
-1%
4%
4%
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD
13%
6%
10%
8%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR
4%
2%
5%
3%
US
DaVita Inc
NYSE:DVA
12.7B USD
104%
5%
13%
10%
Country JP
Market Cap 114.6B JPY
ROE
5%
ROA
4%
ROCE
7%
ROIC
8%
Country US
Market Cap 75.6B EUR
ROE
7%
ROA
2%
ROCE
10%
ROIC
7%
Country US
Market Cap 77.9B USD
ROE
7%
ROA
2%
ROCE
10%
ROIC
7%
Country US
Market Cap 56B USD
ROE
7%
ROA
2%
ROCE
7%
ROIC
4%
Country DE
Market Cap 26B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Country DE
Market Cap 18.8B EUR
ROE
-2%
ROA
-1%
ROCE
4%
ROIC
1%
Country US
Market Cap 19.3B USD
ROE
5%
ROA
2%
ROCE
8%
ROIC
5%
Country US
Market Cap 16.9B USD
ROE
-2%
ROA
-1%
ROCE
4%
ROIC
4%
Country US
Market Cap 17.1B USD
ROE
13%
ROA
6%
ROCE
10%
ROIC
8%
Country DE
Market Cap 13B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Country US
Market Cap 12.7B USD
ROE
104%
ROA
5%
ROCE
13%
ROIC
10%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top